The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Serum Separation Gel Global Market Report 2024, the serum separation gel market is expected to show promising growth in the forecast period.

Market Growth Overview

• Current Market Size
  • The serum separation gel market is set to grow from $8.22 billion in 2023 to $8.92 billion in 2024, at a robust CAGR of 8.5%.
  • Growth drivers include increased healthcare expenditure, higher demand for diagnostic testing, expansion of the healthcare industry, and rising prevalence of chronic diseases.
• Future Market Projections
  • The market is expected to reach $12.58 billion by 2028, with a CAGR of 9.0%.
  • Future growth is driven by the increasing incidence of hematologic disorders, emphasis on point-of-care testing, expansion in emerging markets, and demand for personalized medicine.

Drivers of Market Growth

Rising Demand for Diagnostic Testing

• Importance of Diagnostic Testing
  • Diagnostic testing helps in early disease detection and preventive healthcare measures.
  • Serum separation gel is crucial in separating serum from blood cells, enabling accurate disease analysis.
• Market Impact
  • Increased diagnostic tests drive the demand for serum separation gels.
  • For example, in January 2024, there was a 13% increase in diagnostic tests in the UK compared to January 2020.

Key Players in the Market

• Major Companies
  • Leading companies include Cardinal Health Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Corning Incorporated, and Bio-Rad Laboratories Inc.

View More On The Serum Separation Gel Market Report 2024 – https://www.thebusinessresearchcompany.com/report/serum-separation-gel-global-market-report

Technological Innovations

Introduction of Serum Fast Separator Tubes

• Innovative Solutions
  • Companies are developing novel products like serum fast separator tubes for faster blood sample processing.
  • These tubes use specialized gel and clot activators to speed up serum separation.
• Case Study: Greiner Bio-One
  • In May 2023, Greiner Bio-One launched VACUETTE CAT Serum Fast Separator.
  • This tube accelerates the clotting process, reducing coagulation time to approximately 5 minutes.

Strategic Acquisitions

Abcam Acquires BioVision Inc.

• Expansion of Capabilities
  • In October 2021, Abcam acquired BioVision Inc. for $340 million.
  • This acquisition enhances Abcam’s immunoassay capabilities and expands its range of research tools.

Market Segmentation and Regional Insights

Market Segmentation

• By Type
  • Serum Separation Gel Integrated with Tube
  • Serum Separation Gel Without Tube
• By Formulation
  • Powder Gel
  • Liquid Gel
• By End User
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Diagnostic Laboratories
  • Blood Banks

Regional Dynamics

• Largest Market: North America
  • North America held the largest market share in 2023.
• Fastest-Growing Region: Asia-Pacific
  • Asia-Pacific is expected to experience the fastest growth during the forecast period, driven by increased healthcare investments and technological advancements.

Conclusion

• The serum separation gel market is poised for significant growth, driven by rising healthcare expenditure, increasing demand for diagnostic testing, and technological innovations.
• Strategic acquisitions and the introduction of novel products will further enhance market dynamics.
• With North America leading the market and Asia-Pacific showing rapid growth, the global serum separation gel market is set for a transformative journey, addressing the evolving needs of the healthcare industry.

Request A Sample Of The Global Serum Separation Gel Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15270&type=smp